General Electric Co. to sell its biopharma business to Danaher for $21 billion in cash, plus pension obligations
NEW YORK – General Electric Co. to sell its biopharma business to Danaher for $21 billion in cash, plus pension obligations.
NEW YORK – General Electric Co. to sell its biopharma business to Danaher for $21 billion in cash, plus pension obligations.